Proteome Sciences PLC Asset Resilience Ratio
Proteome Sciences PLC asset resilience ratio. Proteome Sciences PLC (PRM) has an Asset Resilience Ratio of 19.84% as of December 2005. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Proteome Sciences PLC (PRM) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Proteome Sciences PLC (2001–2005)
Asset resilience ratio of Proteome Sciences PLC from 2001 to 2005. This chart shows how Proteome Sciences PLC's Asset Resilience Ratio has changed over time. Read Proteome Sciences PLC (PRM) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Proteome Sciences PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Proteome Sciences PLC's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX1.90 Million | 19.84% |
| Total Liquid Assets | GBX1.90 Million | 19.84% |
Asset Resilience Insights
- Good Liquidity Position: Proteome Sciences PLC maintains a healthy 19.84% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Proteome Sciences PLC Industry Peers by Asset Resilience Ratio
Compare Proteome Sciences PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
Diagnostics & Research | 0.14% |
|
Vijaya Diagnostic Centre Limited
NSE:VIJAYA |
Diagnostics & Research | 15.15% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Proteome Sciences PLC Asset Resilience Ratio by Year (2001–2005)
Proteome Sciences PLC asset resilience ratio by year from 2001 to 2005. The table below shows the annual Asset Resilience Ratio data for Proteome Sciences PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2005-12-31 | 19.84% | GBX1.90 Million ≈ $231.18 |
GBX9.57 Million ≈ $1.17K |
+2.44pp |
| 2004-12-31 | 17.40% | GBX1.80 Million ≈ $219.01 |
GBX10.34 Million ≈ $1.26K |
-15.83pp |
| 2003-12-31 | 33.24% | GBX4.79 Million ≈ $583.41 |
GBX14.43 Million ≈ $1.76K |
+9.01pp |
| 2002-12-31 | 24.23% | GBX3.35 Million ≈ $407.51 |
GBX13.83 Million ≈ $1.68K |
+18.22pp |
| 2001-12-31 | 6.00% | GBX225.00K ≈ $27.38 |
GBX3.75 Million ≈ $455.90 |
-- |
About Proteome Sciences PLC
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in pla… Read more